HT2 VARIABILITY IN UTILIZATION OF INNOVATIVE DRUGS IN EUROPE AS A RESULT OF HEALTH TECHNOLOGY ASSESSMENT AND FUNDING PROCEDURES- EXAMPLES OF TRASTUZUMAB AND CETUXIMAB
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)71994-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)71994-X/fulltext
Section Title :
Section Order :
559
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)71994-X&doi=10.1016/S1098-3015(10)71994-X